The following is a summary of “Effectiveness of Interventions to Disease Management Programs of Patients with Heart Failure: A Systematic Review and Meta-Analysis,” published in the December 2024 issue of Cardiology by Yap et al.
The prevalence of heart failure (HF) is rising globally due to an aging population and higher incidences of risk factors, posing significant public health challenges.
Researchers conducted a retrospective study evaluating the effectiveness of disease management programs (DMPs) in patients following an HF event.
They searched 5 databases—Embase, PubMed, Web of Science, Scopus, and CINAHL—for RCTs comparing DMPs with placebo in patients with HF, 12 studies with 3844 participants were included.
The results showed the intervention group demonstrated improvements in exercise capacity [mean difference (95% CI), 53.33 (43.40–67.26); P<0.00001], physical activity [−5.76 (−8.86 to −2.66); P=0.0003], emotional well-being [−2.32 (−4.39 to −0.25); P=0.03], and QoL [−9.13 (−16.79 to −1.48); P=0.02] compared to the control group. Additionally, the control group had higher hospital admissions (P=0.0002), readmissions (P=0.00001), and mortality due to HF causes (P=0.003).
They concluded that DMPs improved outcomes in patients following an HF event, including exercise capacity, physical activity, emotional well-being, and QoL, and reduced hospital admissions, readmissions, and mortality due to HF.
Source: journals.lww.com/cardiologyinreview/abstract/9900/effectiveness_of_interventions_to_disease.384.aspx
